企業プロフィール
ABVC BioPharma, Inc. 株価・ニュース・カタリスト
- ティッカー:
- ABVC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States and trades on NASDAQ, placing it in the small-cap biotech category
株価パフォーマンス
0.85 USD (-5.56%)
終値
最終更新: 2026年8月17日
32.5M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ABVC closed down 5.56% at $0.8499. No new same-company headline was identified in the current news window.
企業概要
事業概要
ABVC BioPharma is a small biotechnology company with programs spanning areas such as oncology, ophthalmology, and central nervous system health. Its profile is that of a micro-cap development company trying to create value through a mix of early-stage assets and licensing opportunities.
所在地とセクター分類
ABVC is headquartered in the United States and trades on NASDAQ, placing it in the small-cap biotech category. It is a development-stage name with limited commercial scale.
ビジネスモデルの特徴
The business model depends on early clinical development, licensing, strategic partnerships, and financing discipline. Investors usually watch pipeline announcements, trial progress, and whether the company can sustain enough runway to advance its programs.
バイオ業界での位置付け
ABVC sits in the speculative micro-cap side of biotech. The stock is usually driven by announcements, capital structure, and the company's ability to maintain credibility across multiple early programs.
今後のカタリスト
- ABVC BioPharma’s catalysts are its partnered clinical assets and any update that clarifies whether the company can still convert the pipeline into a viable path. The market will care about concrete progress rather than broad promises.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。